Skip to main contentAI and Advanced
/
AHCL · NSEMarket ticker unavailable · configure an authorised index feed
AH
NSE · Equity shares · Biotechnology & Drugs-0.35 · -1.72%
Anlon Healthcare AHCL
NSE:INR 19.95
BSE:INR 14.85
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for AHCL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 20.3
Day rangeINR 19.6 — INR 20.5
52-week rangeINR 9.1 — INR 22.94
Volume4.61 Cr
Market cap802.59
P/E18.94
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)171.97
Net Income (INR Cr)29.09
P/E Ratio18.94
Book Value4.33
EPS0.61
Price/BV4.61Computed
Research path: Interpret Anlon Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
AHCLAnlon Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 373.97 | 181.3 | 128 |
| Other Liabilities Total | 0.37 | 0.24 | 0.22 |
| Long Term Debt | 6.09 | 38.36 | 54.25 |
| Common Stock Total | 53.15 | 39.85 | 16 |
| Other Current Assets Total | 86.85 | 0.33 | 0.32 |
| Total Assets | 373.97 | 181.3 | 128 |
| Cash | 4.37 | 1.45 | 2.27 |
| Total Equity | 230.23 | 80.42 | 21.03 |
| Long Term Investments | 0.98 | Not available | Not available |
| Retained Earnings(Accumulated Deficit) | 177.08 | 40.57 | 5.03 |
| Total Common Shares Outstanding | 53.15 | 53.15 | 53.15 |
| Tangible Book Valueper Share Common Eq | 4.33 | 1.51 | 0.4 |
| Goodwill Net | 0.05 | Not available | Not available |
| Total Liabilities | 143.74 | 100.88 | 106.97 |
| Total Debt | 43.65 | 66.55 | 81.25 |
| Short Term Investments | 0.01 | 0.91 | 0.85 |
| Cashand Short Term Investments | 4.38 | 2.36 | 3.12 |
| Total Receivables Net | 103.87 | 77.49 | 40.34 |
| Notes Payable/Short Term Debt | 37.56 | 19.99 | 20.32 |
| Deferred Income Tax | 5.14 | 2.23 | 2.4 |
| Accounts Receivable-Trade Net | 103.68 | 75 | 38.73 |
| Property/Plant/Equipment Total-Net | 57.71 | 22.82 | 27.3 |
| Minority Interest | 24.57 | Not available | Not available |
| Total Current Liabilities | 107.57 | 60.05 | 50.1 |
| Total Inventory | 113.16 | 50.26 | 41.71 |
| Accounts Payable | 42.19 | 19.64 | 19.99 |
| Other Currentliabilities Total | 27.81 | 11.55 | 2.42 |
| Total Long Term Debt | 6.09 | 38.36 | 54.25 |
| Other Long Term Assets Total | 6.96 | Not available | Not available |
| Total Current Assets | 308.26 | 158.48 | 100.7 |
| Accumulated Depreciation Total | Not available | -12.87 | -11.09 |
| Accrued Expenses | Not available | 0.66 | 0.69 |
| Prepaid Expenses | Not available | 28.04 | 15.21 |
| Current Portof LT Debt/Capital Leases | Not available | 8.21 | 6.69 |
| Property/Plant/Equipment Total-Gross | Not available | 35.68 | 38.39 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.34
Price to Sale Ratio4.67
Margins
Operating Margin 12m26.8
Net Profit Margin 12m16.92
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk48.2
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,938.65 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,380 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,994.45 | 1.69 L | 72.73 | — |
| Cipla | INR 1,410.25 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,120.55 | 1.12 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 52.68%
- FII
- 1.67%
- Other
- 45.65%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Anlon Healthcare Ltd is Rated Hold by MarketsMOJO - MarketsMojoMarket news · 16 Jul 2026, 10:15 am
Anlon Healthcare Ltd is Rated Hold by MarketsMOJO MarketsMojo
Anlon Healthcare Forms New Subsidiary Anlon Biologics for ₹6.5 Lakh Investment - WhalesbookMarket news · 11 Jul 2026, 4:20 pm
Anlon Healthcare Forms New Subsidiary Anlon Biologics for ₹6.5 Lakh Investment Whalesbook
Anlon Healthcare incorporates Anlon Medicare to expand medical devices - scanx.tradeMarket news · 9 Jul 2026, 11:22 pm
Anlon Healthcare incorporates Anlon Medicare to expand medical devices scanx.trade
Anlon Healthcare Invests ₹0.11 Crore in New Medical Device Subsidiary - WhalesbookMarket news · 9 Jul 2026, 8:35 pm
Anlon Healthcare Invests ₹0.11 Crore in New Medical Device Subsidiary Whalesbook
Enterprise value to revenue forward of Anlon Healthcare Limited – NSE:AHCL - TradingViewMarket news · 7 Jul 2026, 3:30 pm
Enterprise value to revenue forward of Anlon Healthcare Limited – NSE:AHCL TradingView
Anlon Healthcare CMD outlines growth strategy in interview - scanx.tradeMarket news · 7 Jul 2026, 12:30 pm
Anlon Healthcare CMD outlines growth strategy in interview scanx.trade
Corporate actions
Events
- board MeetingsAudited Results
- bonusBonus issue of equity shares in the ratio of 1:1 of Rs. 2/-.
- splitsStock split from Rs. 10/- to Rs. 2/-.
- annual General MeetingPOM
- board MeetingsBonus issue & Stock Split
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Anlon Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Anlon Healthcare Limited is an India-based company, which is engaged in the business of manufacturing of high purity advance pharmaceutical intermediates (Pharma Intermediate) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients and active pharmaceutical ingredients (APIs) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF), such as tablet, capsules, ointment, syrup, and ingredients in nutraceuticals formulations, personal care products and animal health products. Its products span across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Its products include 3-(1-cyanoethyl) benzoic acid (CEBA), ketoprofen ethyl ester (KEE), Dex-Ketoprofen, Loxoprofen Acid, Ketoprofen, Silodosin, Omeprazole, L-Arginine, Piroctone olamine, Ticagrelor, and others.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- AHCL
- BSE Code
- 544497
Questions
Stock FAQ
What is the symbol and ISIN of Anlon Healthcare?
Anlon Healthcare has the symbol AHCL and ISIN - INE0Y8W01025.
What is the current price of Anlon Healthcare?
Anlon Healthcare is currently trading at INR 19.95.
What are the year high and year low of Anlon Healthcare?
Anlon Healthcare has a year high of INR 22.94 and a year low of INR 9.10.
What is the market capitalization of Anlon Healthcare?
Anlon Healthcare has a market capitalization of INR 802.59 crore.
What is the P/E ratio of Anlon Healthcare?
Anlon Healthcare has a P/E ratio of 18.94.
What is the dividend yield of Anlon Healthcare?
Anlon Healthcare has a dividend yield of 0.00%.
How is the financial performance of Anlon Healthcare based on revenue, net income, and EPS?
Anlon Healthcare has revenue of INR 171.97 crore, net income of INR 29.09 crore, and EPS of INR 0.59.
What is the book value of Anlon Healthcare?
Anlon Healthcare has a book value of INR 4.33.
What is the debt-to-equity ratio of Anlon Healthcare?
Anlon Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Anlon Healthcare?
Anlon Healthcare has a price-to-book ratio of 4.61 and a price-to-sales ratio of 4.67.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.